MedMira Inc (MIR : TSX-V)
Common Stock
$0.07
CAD
-0.01 (-7.14%)
Last updated: 2026-06-23
MIR
MedMira Inc
WealthAwesomePerformance
1 Day
-7.14%
1 Week
+8.33%
1 Month
+8.33%
YTD
+0.00%
Key Statistics
Market Cap
$45.61M
52W High
$0.11
52W Low
$0.05
P/E Ratio
-
50 Day MA
$0.06
200 Day MA
$0.07
Beta
0.78
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/23/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 4,462 |
| 6/22/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 247,000 |
| 6/19/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 5,462 |
| 6/18/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 53,748 |
| 6/17/2026 | $0.06 | $0.07 | $0.06 | $0.07 | $0.07 | 44,157 |
| 6/16/2026 | $0.07 | $0.07 | $0.06 | $0.06 | $0.06 | 65,032 |
| 6/15/2026 | $0.06 | $0.07 | $0.06 | $0.07 | $0.07 | 229,462 |
| 6/12/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 10,000 |
| 6/11/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 11,962 |
| 6/10/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 105,000 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MIR's historical volatility
30-Day Vol
98.2%
Annualized
90-Day Vol
105.3%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.07
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.07 | C$0.05 – C$0.09 |
| 60 trading days | C$0.07 | C$0.04 – C$0.10 |
| 90 trading days | C$0.07 | C$0.04 – C$0.12 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About MedMira Inc
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.
Financials
- Revenue (TTM)
- $188,496
- EBITDA
- $-2.40M
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- 0.00
- Book Value
- -0.03
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About MIR
Articles Featuring MIR.V
Latest articles and analysis covering MIR.V
